A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)
Clinical trial NCT03631784 · COMPLETED
Trial details
- NCT number
- NCT03631784
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-19
- Primary completion
- 2021-10-18
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.